文献速递糖尿病

香港2型糖尿病合并新发慢性肾脏病患者的医疗费用差异:潜在类别轨迹分析

Differential healthcare costs in individuals with type 2 diabetes and incident chronic kidney disease in Hong Kong: a latent class trajectory analysis.
PubMed 文献 · Diabetologia · 2026-03-18

该研究基于香港糖尿病登记队列(2007-2019)中2886例2型糖尿病合并新发慢性肾脏病(CKD)患者,采用潜在类别分析(LCA)按14个变量分为4类,并用分层广义线性混合模型评估各类别纵向医疗费用。随访109784人年期间CKD发病率为26.29/1000人年,人均年费用为4395±11947美元;年轻发病类别在CKD发病当年费用最高。

要点

  • 年轻发病且合并症中等、多重用药者CKD发病当年人均年费用最高(6087±15519美元)。
  • 中年发病、合并症少且用药少者后续医疗费用亦升高,主要由CKD后门诊和精神科诊疗驱动。
  • 基于基线特征的分层有助于识别CKD相关高医疗费用人群以支持早期干预决策。

核心结论

  • 年轻发病的2型糖尿病合并新发CKD个体在CKD发病当年医疗费用最高。
  • 中年发病、基线合并症较少且治疗强度较低者后续医疗费用也升高。

研究设计与样本

  • 研究为前瞻性香港糖尿病登记队列(2007-2019)分析,纳入2886例2型糖尿病合并新发CKD且42项属性数据完整的中国个体。
  • 采用潜在类别分析(LCA)筛选14个变量进行分类,并用分层广义线性混合模型评估各类别纵向医疗费用。

主要发现

  • 随访109784人年期间CKD发病率为26.29/1000人年,人均年费用为4395±11947美元(均值±标准差)。
  • 类别1占18.3%,人均年费用6087±15519美元,发病年龄44.4±10.3岁,25.6%有中等或高Elixhauser合并症指数(ECI)评分,90.2%使用至少三种药物。
  • 类别2占21.2%,人均年费用3822±9816美元,发病年龄66.9±6.9岁,27.8%有中等或高ECI评分,70.7%使用至少三种药物。
  • 类别3占33.9%,人均年费用4260±11725美元,发病年龄54.2±10.0岁,14.0%有中等或高ECI评分,15.6%使用至少三种药物。
  • 类别4占26.5%,人均年费用3923±10957美元,发病年龄54.1±7.6岁,25.3%有中等或高ECI评分,98.9%使用至少三种药物。

关键数值与推荐

  • 类别1和类别3在CKD发病当年费用最高,类别1基线合并症多于类别3。
  • 类别1高费用由多种医疗服务贡献,类别3费用主要归因于CKD后门诊和精神科诊疗。

临床怎么用

  • 可依据发病年龄、合并症负担和用药数量对2型糖尿病合并新发CKD患者进行费用风险分层。
  • 对年轻发病及中年发病低合并症患者应关注CKD发病前后的医疗资源使用,以支持早期干预决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Chronic kidney disease (CKD) represents a major and costly comorbidity in type 2 diabetes management. Identifying individuals with high healthcare costs due to CKD will support decision-making for early intervention. We used latent class analysis (LCA) to classify Chinese individuals with type 2 diabetes and incident CKD based on their demographic and clinical profiles. METHODS: For this study, 2886 individuals with type 2 diabetes and incident CKD and complete data for 42 attributes were selected from the prospective Hong Kong Diabetes Register cohort (2007-2019). We used LCA to select 14 variables to classify participants, followed by a hierarchical generalised linear mixed model to evaluate longitudinal healthcare costs among class memberships. RESULTS: During 109,784 person-years of follow-up, the incidence of CKD was 26.29 per 1000 person-years with a per-patient-per-year (PPPY) cost of US$4395 ± 11,947 (mean ± standard deviation). The four distinct classes used in the LCA based on baseline profiles were as follows: Class 1 (18.3%; PPPY: US$6087 ± 15,519), namely those who were young at onset (44.4 ± 10.3 years), had moderate comorbidities (25.6% had a moderate or high score on the Elixhauser Comorbidity Index [ECI]) and used multiple medications (90.2% used at least three medications); Class 2 (21.2%; PPPY: US$3822 ± 9816), namely those who had old-age onset (66.9 ± 6.9 years), had moderate comorbidities (27.8% had a moderate or high ECI score) and used multiple medications (70.7% used at least three medications); Class 3 (33.9%; PPPY: US$4260 ± 11,725), namely those who were middle-aged at onset (54.2 ± 10.0 years), had few comorbidities (14.0% had a moderate or high ECI score) and used few medications (15.6% used at least three medications); and Class 4 (26.5%; PPPY: US$3923 ± 10,957), namely those who were middle-aged at onset (54.1 ± 7.6 years), had moderate comorbidities (25.3% had a moderate or high ECI score) and used multiple medications (98.9% used at least three medications). Class 1 (young onset) and Class 3 (middle-aged onset) incurred the highest cost during the year of CKD onset, with those in Class 1 having more comorbidities than those in Class 3 at baseline. Multiple healthcare services contributed to the high healthcare costs in Class 1, with costs in Class 3 attributed mainly to post-CKD outpatient and psychiatric care. CONCLUSIONS/INTERPRETATION: Those with young-onset type 2 diabetes incurred the highest cost during the year of CKD onset. Individuals with middle-aged onset type 2 diabetes with fewer comorbidities and less intensified treatment at baseline also had subsequent increased healthcare costs.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Du Y, Zhang M, Li AQY, et al. Differential healthcare costs in individuals with type 2 diabetes and incident chronic kidney disease in Hong Kong: a latent class trajectory analysis. Diabetologia. 2026. PMID: 41848900. doi:10.1007/s00125-026-06698-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。